Learn More
Apexbio Technology LLC RI-2 1417162-36-7 10mg

Supplier: Apexbio Technology LLC B588110
RI-2 (CAS 1417162-36-7) is a reversible small molecule inhibitor of RAD51 a conserved protein essential for homologous recombination (HR)-mediated DNA repair RAD51 is frequently overexpressed in cancer cells making it a relevant target for oncology research RI-2 inhibits RAD51 activity with an IC50 of 44 17 M impairing RAD51-mediated DNA binding in vitro Unlike some related compounds RI-2 does not react with glutathione after 24 hours of incubation indicating it lacks irreversible Michael acceptor reactivity RI-2 is under preclinical investigation as a research tool for studying HR pathways and potential strategies to sensitize cancer cells to DNA-damaging therapies
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.